Apollo Endosurgery Investor Relations Material
Latest events
Q3 2022
Apollo Endosurgery
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Apollo Endosurgery Inc
Access all reports
Apollo Endosurgery, Inc. engages in the design, development, and commercialization of medical devices. The company develops devices that use endoscopic procedure to treat various clinical conditions. Its products include ORBERA intragastric balloon system for the treatment of obesity; OverStitch Endoscopic Suturing System for the treatment of suturable gastrointestinal defects; and transoral overstitch device for transoral endoluminal suturing and endoscopic full thickness plication procedures.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
APEN
Country
🇺🇸 United States